Tubulis

Raised $358M in a Series C round, announced 15 October 2025.

Total raised: $358M

Latest round Series CCountry GermanySector Health

Round

$358MSeries C, 15 October 2025

Advance TUB-040 into earlier lines and more tumor types, plus TUB-030 and preclinical programs

Amount: $358M
Stage: Series C
Announced: 15 October 2025
Lead: Venrock Healthcare Capital Partners
Other investors: Wellington Management, Ascenta Capital, EQT Life Sciences, Frazier Life Sciences, Deep Track Capital
Use of funds: Advance TUB-040 into earlier lines and more tumor types, plus TUB-030 and preclinical programs
Checked: Announced by the company
Sources: Tubulis raises €308M Series C biospace.com
Tubulis raises €308M Series C funding.tech.eu

Company

Develops antibody-drug conjugates for cancer

Based in: Munich, Germany
Sector: Health
Website: tubulis.com ↗

Questions

How much has Tubulis raised?

Tubulis raised $358M in a Series C round, announced on 15 October 2025.

Who invested in Tubulis?

Venrock Healthcare Capital Partners led. Investors include Venrock Healthcare Capital Partners, Wellington Management, Ascenta Capital, EQT Life Sciences, Frazier Life Sciences and Deep Track Capital.